Table 4.
No. | POD 0–1 | POD 2 | POD 3 | POD 4 | POD 5 | POD 6 | POD 7 | POD 8 | |
---|---|---|---|---|---|---|---|---|---|
Group | |||||||||
Controls, mg | 40 | 52.86 ± 52.0 | 29.9 ± 42.53 | 16.0 ± 26.83 | 7.11 ± 10.27 | 4.13 ± 3.93 | 8.50 ± 5.74 | 12.00 ± 2.83 | 0 ± 0.00 |
TAP-Cath, mg | 48 | 7.25 ± 12.82 | 5.17 ± 7.05 | 3.60 ± 4.35 | 2.95 ± 4.24 | 2.00 ± 2.31 | 2.00 ± 2.83 | 4.00 ± 0.00 | — |
TAP-LB, mg | 40 | 1.88 ±3.97 | 2.12 ± 4.95 | 2.23 ± 4.12 | 2.00 ± 2.31 | — | — | — | — |
Global p† | <0.0001 | <0.0001 | 0.0181 | 0.1998 | 0.2685 | 0.1391 | — | — | |
TAP-Cath vs. controls‡ | <0.0001 | 0.0026 | 0.0146 | — | — | — | — | — | |
TAP-LB vs. controls‡ | <0.0001 | 0.0009 | 0.0075 | — | — | — | — | — | |
TAP-LB vs.TAP-Cath‡ | 0.0081 | 0.0270 | 0.2157 | — | — | — | — | — |
POD, postoperative day; TAP-Cath, transversus abdominis plane-catheter; TAP-LB, transversus abdominis plane-liposomal bupivacaine.
Intravenous morphine equivalents (in milligrams).
Determined using the Welch analysis of variance using a significance level of 0.05.
Pairwise comparisons were performed using the Welch t test with a Bonferroni correction of 0.016.